What is Alodokter?
Headquartered in Jakarta, Alodokter operates as a sophisticated telemedicine platform that bridges the gap between patients and healthcare providers. By leveraging proprietary software services, the company facilitates virtual consultations, medical content distribution, and integrated health management tools. Its market position is defined by its ability to scale digital health infrastructure in a complex, geographically diverse market, effectively digitizing the patient journey from symptom checking to professional medical advice.
How much funding has Alodokter raised?
Alodokter has raised a total of $42.5M across 3 funding rounds:
Series A
$2.5M
Series B
$7M
Series C
$33M
Series A (2016): $2.5M with participation from Golden Gate Ventures and 500.com
Series B (2017): $7M led by SoftBank Corp
Series C (2020): $33M supported by Sequis Life, Hera Capital, Softbank Ventures Asia, Golden Gate Ventures, MDI Ventures, Philips, Dayli Partners, and Heritas
Key Investors in Alodokter
SoftBank Corp
SoftBank Group Corp. is a global technology holding company driving innovation across telecommunications, internet services, and artificial intelligence, supporting the scaling of transformative technologies worldwide.
Golden Gate Ventures
Golden Gate Ventures is a leading venture capital firm specializing in early-stage investments across Southeast Asia, focusing on high-growth sectors such as consumer internet and digital media.
MDI Ventures
MDI Ventures is a global multi-stage venture capital firm focused on investing in local founders and startups in Indonesia, aiming to drive innovation and digital transformation across various sectors.
What's next for Alodokter?
With the infusion of recent capital, Alodokter is well-positioned to accelerate its enterprise-level expansion and deepen its technological moat. The strategic focus is expected to shift toward enhancing AI-driven diagnostic support and expanding its network of healthcare partners to ensure seamless service delivery. As the company matures, the emphasis will likely remain on operational efficiency and the integration of advanced health-tech features that cater to the evolving needs of the Indonesian population, further cementing its role as a critical component of the regional digital health infrastructure.
See full Alodokter company page
